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While regulation of cell cycle progression has been extensively 
studied, most of the metabolic needs at different phases of the cell 
cycle and how the cells fulfil the metabolic requirements of cell 
division remain elusive.
Phospholipids (PL) are essential constituents of all 
membranes, and their content must therefore be duplicated 
during the cell cycle. The synthesis and turnover of the main 
PL in mammalian cells, phosphatidylcholine, occurs throughout 
the cell cycle with maximal net accumulation during the S 
phase, to support cellular growth.1-3 Numerous studies have 
contributed to the understanding of the mechanisms that 
regulate phosphatidylcholine metabolism during G
1
 and S4-8 and 
its importance to surpass the G
1
/S boundary.9,10 The importance 
of PL synthesis and turnover in other phases of the cell cycle is 
less well known.
At the end of mitosis, many processes involving membrane 
expansion and remodeling take place. The addition of surface 
during cellular division has long been recognized, and it has been 
studied in a variety of organisms, including mammals.11-13 Despite 
the importance of vesicular trafficking as a mean of surface 
membrane delivery, the source of this membrane is less well 
known. It has been shown that previously internalized plasma 
membrane is recycled to the cell surface as the cells divide;13 
however, de novo synthesis and degradation of different PL at 
the end of mitosis has also been documented.7,14-16 In addition, 
nuclear envelope reassembly and expansion occurs upon mitotic 
exit and involves extensive membrane reorganization.17,18
Fatty acids (FA) are essential building blocks of PL, thus a 
correct supply is required for membrane synthesis. Cancer cells 
engage in an increased de novo FA synthesis as part of their 
anabolic reprogramming to support proliferation.19-21 However, 
whether the endogenous synthesis of FA is regulated in a cell 
cycle-dependent manner is currently not known. Fatty acids, 
mainly palmitic acid, are synthesized endogenously by the 
consecutive action of 2 enzymes: acetyl-CoA carboxylase 1 
(ACC) and fatty acid synthase (FASN). The rate-limiting 
enzyme of this pathway, ACC, is negatively regulated by palmitic 
acid. Interestingly, accumulation of free palmitic acid impairs 
cytokinesis in cancer and normal cells.22 ACC is also inhibited 
by 5′ AMP-activated kinase (AMPK). In addition to its well-
established role as a metabolic regulator, AMPK has been recently 
implicated in mitosis progression.23 Furthermore, the activity of 
SREBP1, a major transcriptional regulator of lipogenic genes, 
is enhanced by hyperphosphorylation in mitosis.24,25 Together, 
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Although the regulation of the cell cycle has been extensively studied, much less is known about its coordination 
with the cellular metabolism. Using mass spectrometry we found that lysophospholipid levels decreased drastically from 
G2/M to G1 phase, while de novo phosphatidylcholine synthesis, the main phospholipid in mammalian cells, increased, 
suggesting that enhanced membrane production was concomitant to a decrease in its turnover. In addition, fatty acid 
synthesis and incorporation into membranes was increased upon cell division. the rate-limiting reaction for de novo 
fatty acid synthesis is catalyzed by acetyl-CoA carboxylase. As expected, its inhibiting phosphorylation decreased prior 
to cytokinesis initiation. Importantly, the inhibition of fatty acid synthesis arrested the cells at G2/M despite the presence 
of abundant fatty acids in the media. our results suggest that de novo lipogenesis is essential for cell cycle completion. 
this “lipogenic checkpoint” at G2/M may be therapeutically exploited for hyperproliferative diseases such as cancer.
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these observations suggest that lipogenesis may be differentially 
regulated at the mitotic exit.
The importance of cellular metabolism for proliferation has 
gained new interest because of its role in supporting transformation 
and its potential in being targeted for treatment.26 Recent evidence 
suggests that the core machinery that regulates cell cycle progression 
is involved in cellular metabolic programming, in addition to 
the well-established regulation of nucleotide synthesis.8,25,27-30 A 
better knowledge of the metabolic requirements during the cell 
cycle may help to identify new targets for cancer treatment and to 
design the schedule of combined therapies.31 Here, we show that 
cells engage in an active membrane synthesis at the mitotic exit 
that is necessary to complete the cell cycle.
Results
Metabolic profiling reveals cyclic changes in several 
metabolic pathways
To screen for metabolic changes during the cell cycle, a 
metabolic profiling by LC-MS/GC-MS in double thymidine 
block (2TB)-synchronized HeLa cells was performed. Sixty-
nine metabolites were found to be different across the various 
phases of the cell cycle (Table S1; Fig. S1). Figure 1A shows the 
distribution of the biochemical classes/pathways they belonged 
to. Among the most represented pathways that differed across the 
cell cycle were those related to polyamine, LysoPL, and glucose 
metabolism (Fig. 1A; Fig. S1). Several enzymes of polyamine and 
glucose metabolism have been previously shown to be regulated 
in a cell cycle-dependent manner.28,32,33 Encouragingly, most of 
the metabolites belonging to these pathways were also found to 
be cyclic in our profiling, suggesting that our model was suitable 
for identifying cell cycle-regulated pathways.
More than 20% of the metabolites that differed 
across the cell cycle were LysoPL (Fig. 1B; Fig. S1). Both 
lysophosphatidylcholines (LysoPC) and lysophos-
phatidylethanolamines (LysoPE) were abundant. Of particular 
interest, the LysoPC and LysoPE showed higher values at G
2
/M than 
at G
1
 phase of the cell cycle, irrespective of their levels at S phase. 
Glycerophosphorylcholine and glycerophosphoethanolamine, 
degradation products of LysoPC and LysoPE, respectively, were 
unchanged during the cell cycle, suggesting that the reacylation 
of LysoPL to form new PL (Fig. 1C) increased from G
2
/M to 
G
1
. Moreover, glycerol-3 phosphate level (a substrate for de novo 
PL synthesis) also decreased from G
2
/M to G
1
 (Fig. S1), further 
suggesting that important changes in membrane metabolism 
occur in this period of the cell cycle.
The decrease in LysoPL content is accompanied by an 
augmented membrane synthesis as the cells reach G
1
The bulk of phosphatidylcholine is synthesized de novo 
by the CDP–choline pathway. We estimated the rate of 
phosphatidylcholine synthesis during the cell cycle. As expected, 
the incorporation of [14C] choline into the lipids peaked as the 
cells progressed from G
2
/M (8 h) to G
1
 (10 h) phase of the cell 
cycle (Fig. 2A). The synthesis of phosphatidylcholine decreased 
slightly when the cells were pulsed during G
1
 (10 to 12 h), 
and the lowest levels were seen at S and G
2
/M phases (4 and 
8 h, respectively). Interestingly, the maximal incorporation of 
choline did not correspond to the peak of any phase of the cell 
cycle (Fig. S2A–D), but rather the time when the cell number 
doubled, suggesting that the cells synthesized membranes during 
cellular division. Importantly, these changes were independent of 
cellular size or protein content (Fig. S3A). Moreover, the total FA 
content per cell at G
1
, which represents mainly those acylated in 
PL, was more than half of the total FA content of those at G
2
/M, 
Figure 1. Metabolic profiling reveals extensive changes in metabolite levels during the cell cycle. HeLa cells were synchronized by 2tB and the metabo-
lite levels, at different time points after the release, were obtained by GC/MS or LC/MS and normalized to total protein content. the levels of the metabo-
lites at different phases of the cell cycle were deconvoluted using FACS data as described under “Materials and Methods”. (A) Distribution of the cyclic 
metabolites in biochemical classes and (B) relative levels of the lysophosphatidylcholine (LysopC) and lysophosphatidylethanolamine (Lysope) species. 
(C) Schematic model of pC/pe metabolism.  FA, fatty acids; pC, phosphatidylcholine; pe, phosphatidylethanolamine; GpC, glycerophosphorylcholine; 
Gpe, glycerophosphoethanolamine.
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indicating that the net accumulation of lipids occurred upon cell 
division, either late in mitosis or early in G
1
.
De novo fatty acid synthesis increases as the cells divide
Both LysoPL reacylation and de novo PL synthesis require 
FA. Thus, we estimated the de novo FA synthesis during the 
cell cycle in synchronized cells. Acetate incorporation into lipids 
peaked when the cells were pulsed from G
2
/M to G
1
 (8 to 10 h) 
(Fig. 3A), and the overall pattern resembled the one for choline 
incorporation (Fig. 2). Accordingly, approximately 80% of the 
total acetate incorporated was used for PL synthesis (Fig. 3B). In 
addition, acetate relative distribution was also slightly changed at 
10 h, with a higher channeling of FA toward PL at the expense of 
neutral lipids (Fig. 3B).
One of the main physiological sources of acetyl-CoA 
for FA synthesis is glutamine. As observed with acetate, the 
incorporation of [14C] glutamine into lipids peaked as the 
cells divided (Fig. S3B), and, as before, most of the radiolabel 
was associated with FA (Fig. 3C). The incorporation of [14C] 
glutamine into lipids was also increased upon cell division in 
thymidine–nocodazole-synchronized cells (Fig. S3C).
In addition to their de novo synthesis, cells incorporate FA 
from the extracellular milieu. However, unlike de novo FA 
synthesis, the uptake of exogenous radiolabeled palmitic acid did 
not change during the cell cycle in HeLa cells (Fig. 3D).
Overall, these results show that de novo FA synthesis increased 
during the cellular division to support membrane production, 
while the utilization of exogenous FA is unchanged.
Endogenously synthesized fatty acids are required to 
complete cellular division
To determine the importance of the increase in FA synthesis 
for cell cycle progression, we incubated HeLa cells with C75, an 
inhibitor of fatty acid synthase, under conditions that decreased 
FASN activity approximately 70% (Fig. 4A). C75 caused a 
marginal decrease in viability (≤20% in different experiments, 
data not shown) and a marked enrichment in the G
2
/M 
population, as assessed by flow cytometry in HeLa cells (Fig. 4B). 
C75 caused a similar increase of cells with 4N amount of DNA in 
other cell lines (Fig. S4A). Cyclin B1 level was markedly increased 
in C75-treated HeLa cells (Fig. 4C), whereas cyclin A, which is 
degraded earlier than cyclin B1,34 showed no changes, suggesting 
that the inhibition of FA synthesis arrested the cells at mitosis 
before ana/telophase.35 Moreover, ~10% of the viable cells were 
recovered in the conditioned media (data not shown), and they 
showed high levels of cyclin B1, in keeping with the known looser 
attachment to the substrate during mitotic rounding (Fig. 4C, 
conditioned media).
It is worth noting that C75 treatment was done in the presence 
of 10% FBS, thus plenty of FA were available to the cells from the 
media. Consistently, the depletion of lipids from the media had 
no effect on the cell cycle distribution in asynchronous (Fig. 4D, 
inset) or synchronized populations (Fig. S4B). Even a long-
term deprivation of exogenous lipids had no significant impact 
on proliferation (Fig. 4D). Moreover, the addition of exogenous 
palmitic acid was unable to rescue the cell cycle arrest (Fig. S4C). 
Thus, HeLa cells required endogenous fatty acid synthesis to 
complete cellular division.
AMPK activity toward ACC decreases at the mitotic exit
To evaluate possible regulatory mechanisms for the observed 
metabolic changes, we measured the mRNAs of different 
lipogenic enzymes, as well as that of some important ones for 
cytosolic NADPH production and Krebs cycle, during the cell 
cycle. We found no changes in the mRNA level (Fig. S5) or the 
Figure 2. Membrane synthesis increases from G2/M to G1. the cells were synchronized by 2tB. (A) Cells were pulsed with [
14C]choline for 2 h prior their 
harvesting, and the radioactivity associated to the lipid fraction was determined by scintillation counting and normalized to total protein content. (B) 
the total fatty acid content at G1 (12 h), S (4 h), and G2/M (8 h) was determined by gas chromatography using C23:0 as internal standard and normalized 
to cell number. the values are plotted as mean ± SD of a representative experiment. *P < 0.05 ANoVA and tukey.
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protein content (Fig. S6) of any of the enzymes tested through 
the cell cycle. The rate-limiting enzyme of de novo FA synthesis, 
ACC, is inactivated by AMPK-directed phosphorylation on the 
S79 residue. To accurately estimate the phosphorylation status of 
AMPK and ACC from mitosis to G
1
, we synchronized the cells at 
early mitosis by thymidine–nocodazole treatment. In thymidine–
nocodazole-synchronized cells, AMPK and ACC were highly 
phosphorylated at time 0 (nocodazole block) (Fig. 5A). pAMPK 
decreased rapidly upon cell cycle release, as did its target, pACC 
(Fig. 5A), which occurred just prior to cytokinesis initiation 
(Fig. 5B, right panel) . Both increased again as the cells reached 
G
1
 phase after 2 h (Fig. 5B, left panel). As expected, the synthesis 
of FA during this period mirrored the ACC phosphorylation 
status (Fig. 5C) Moreover, continuous activation of AMPK by the 
new small molecule MT 63–7836 caused an increase in cells with 
G
2
/M amount of DNA, which was not reverted by the addition 
of exogenous palmitate (Fig. 5D) Furthermore, the inhibition 
of fatty acid synthesis downstream of ACC (by C75) arrested 
the cells at some interval between metaphase and telophase, 
when cyclin B1 was still high (Fig. 4C) but pAMPK/pACC 
Figure 3. De novo fatty acid synthesis, but not the incorporation of exogenous fatty acids, increases as the cells divide. HeLa cells were synchronized 
by 2tB and released with fresh media as described under “Materials and Methods”. the cells were pulsed with (A) [14C]acetate, (C) [14C]glutamine, or (D) 
[14C]palmitate for 2 h prior their harvesting. the radioactivity associated to the lipid fraction was determined by scintillation counting and normalized 
to total protein content. (B) the incorporation of [14C]acetate into different lipid species was estimated by thin layer chromatographic analysis of total 
lipids and scintillation counting. the values are plotted as mean ± SD of a representative experiment (except for [B], in which only one experiment was 
done). *P < 0.05 ANoVA and tukey.
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levels were low (Fig. 5E), suggesting that the final products of 
the pathway (de novo synthesized FA) were required to progress 
to G
1
, independently of the pAMPK-ACC status. These results 
suggest that the increase in FA synthesis may be regulated by 
the induction of ACC activity driven by a decreased AMPK 
activation at the end of mitosis.
Discussion
Utilizing a synchronized population of cancer cells, we have 
shown that a decrease in LysoPL content from G
2
/M to G
1
 was 
accompanied by an increase in the de novo synthesis of FA, 
substrates for PL production, and phosphatidylcholine, the main 
PL in mammalian membranes, suggesting that a coordinated 
decrease in membrane turnover and increased PL synthesis 
occurred at the mitotic exit. Moreover, we showed that the 
inhibition of FA synthesis arrested the cells at G
2
/M, probably 
at early M, indicating that membrane production started 
before G
1
 and was necessary to complete cellular division. The 
incorporation of exogenous FA did not change during the cell 
cycle, nor did their depletion affect the cell cycle distribution, 
supporting the notion that endogenously synthesized FA are 
required to sustain cellular proliferation.
How these changes in lipid metabolism are coordinately 
regulated at the mitotic exit is yet to be determined. To this 
end, we showed that the activity of AMPK toward its metabolic 
target ACC is high at the beginning of mitosis and decreases 
at the end of it, in a manner consistent with the dynamics of 
the de novo FA synthesis. Continuous activation of AMPK by a 
small molecule led to an increase of cells with G
2
/M amount of 
DNA, indicative of mitotic arrest. Previous studies have shown 
that AMPK associates with the mitotic apparatus37 and regulates 
Figure 4. Impaired fatty acid synthesis, but not exogenous fatty acid depletion, arrests the cells at G2/M. HeLa cells were incubated with 20 μg/ml of 
fatty acid synthase inhibitor (C75) or vehicle (DMSo) for 24 h. Cell extracts were assayed for FASN activity (A). Alternatively, the cells were pulsed with 
BrdU and the cell cycle distribution was assessed by FACS (B) and immunoblotting analysis of cyclins levels (C). to assess the importance of exogenous 
fatty acids for cell cycle progression, the cells were incubated with regular or charcoal-stripped FBS (CS-FBS) for 24 h and analyzed by FACS (D, inset). 
the sustained effect of exogenous lipid depletion on proliferation was estimated by counting of cells grown in CS-FBS for up to 72 h (D). *P < 0.0001 
Chi-square and Fisher exact test (B).
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several proteins related in mitosis and cytokinesis.23 Therefore, 
it is likely that AMPK orchestrates the completion of mitosis by 
coordinately regulating chromosomal segregation, cytoskeleton 
rearrangement, and membrane synthesis.
Overall, our study shows that extensive changes in FA and 
PL metabolism occur during mitotic exit. Our data challenge 
and to some extent complement the current view in which lipid 
accumulation occurs only at S phase.38 Our results are consistent 
with a biphasic model of PL/FA accumulation: one phase 
classically associated with cellular growth and another, from 
G
2
/M to G
1
, necessary to complete cellular division (Fig. 6). This 
model helps to explain the repeatedly observed phenomenon that 
the impairment of FA synthesis causes cell cycle arrest at G
2
/M 
in yeast39,40 and mammalian cells.41-43 Moreover, the knockdown 
of fatty acid synthase as well as a choline deficient-diet alters 
the expression of genes important for G
2
/M progression and 
cytokinesis in human cells.44,45 LysoPL analogs, which alter both 
phosphatidylcholine synthesis and turnover,46 also induce cell 
cycle arrest at G
2
/M or at G
1
 and G
2
/M in different cancer and 
transformed cells.47-49 Importantly, the arrest point depends on 
the time when the lipid perturbation starts (after or before the 
G
1
/S boundary),48 highlighting the 2 “lipogenic checkpoints” 
(Fig. 6).
The increasing interest in lipogenic enzymes as possible targets 
for cancer treatment and the development of inhibitors for this 
pathway20,21,50,51 together with those for cell cycle-related kinases 
raises the possibility of combined therapy. In this context, the 
arrest at G
2
/M caused by the reduction in PL/FA synthesis might 
be especially important for therapeutic intervention in p53-
deficient cells, since their G
1
 arrest checkpoint is impaired.52,53 
The knowledge of the metabolic requirements during the cell 
cycle and the effect of metabolic perturbations on cell cycle 
progression will be necessary for the design of therapeutic 
schedules and may be determinant of its outcome.31
Figure 5. AMpK-mediated inhibitory phosphorylation of Acetyl-CoA Carboxylase decreases as the cells divide. HeLa cells, synchronized at early mitosis 
by thymidine-nocodazole block, were released and harvested every 15 min. the levels of pAMpK and pACC were assessed by western blot (A). the 
initiation and completion of cytokinesis was determined by counting hourglass-shaped cells and doublets, total cell number and by FACS analysis (B). 
the incorporation of [14C] acetate into lipids was estimated with 30 min pulse in nocodazole-blocked (time cero) or released cells (C). HeLa cells were 
incubated with the AMpK activator Mt 63–78 (25 μM) for 24 h in the presence or absence of 100 μM palmitic acid (with BSA in a 2:1 molar ratio), and 
cell cycle profile was assessed (D). Alternatively, cells were incubated with 20 μg/ml of fatty acid synthase inhibitor (C75) or vehicle (DMSo) for 24 h and 
pAMpK and pACC levels were assessed by western blot (E).
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Materials and Methods
Cell culture and synchronization
Among several cellular models and synchronization protocols, 
we achieved highly synchronized populations only with HeLa 
cells (Table S2), thus we used this cell line for our synchronization 
experiments. HeLa cells were routinely grown in DMEM 
supplemented with 10% FBS, 100 units penicillin/ml, and 100 
µg streptomycin /ml (P/S), 37 °C, 5% CO
2
, and 100% humidity. 
One week prior to seeding for the experiments, the media changed 
to low glucose DMEM, which approximates normal blood glucose 
levels in vivo, supplemented with 10% FBS and P/S. Unless 
otherwise stated, 3.2 × 105 HeLa cells were seeded in 60-mm 
dishes and allowed to grow for 24 h. Cells were synchronized at 
the G
1
/S boundary by double thymidine block (2TB) or at mitosis 
by thymidine–nocodazole block as previously described.54 A brief 
description is provided in Supplemental Methods.
Cell cycle analysis
HeLa cells were incubated with 10 μM 5-Bromo-2’-
deoxyuridine (BrdU) for 1–2 h before harvesting. Cells were 
processed for FACS analysis using FICT-conjugated anti-BrdU 
antibody (BD Biosciences) according to the manufacturers’ 
directions in a FACScan flow cytometer (Becton Dickinson) and 
analyzed with ModFit or FlowJo software. For the estimation 
of cytokinesis initiation, thymidine–nocodazole-synchronized 
cells were harvested every 15 min, and the number of hourglass-
shaped cells or doublets were counted from 50 images.
Metabolic profiling and data deconvolution
1.33 × 106 HeLa cells were seeded in quintuplicate 150-mm 
dishes, synchronized by 2TB, and harvested at the indicated time 
points. Cells were trypsinized and aliquots were used for protein 
determination. The remaining sample was kept at −80 °C until 
processed by Metabolon, as described Sreekumar et al.55 The 
metabolite levels were normalized to the total protein content 
and deconvoluted as follows. For the analysis we used metabolites 
that had at least 3 measurements for each time point. To estimate 
average levels of each metabolite at each stage of the cell cycle we 
fitted a robust linear regression model of the form: 
where Ym are observed levels of m-th metabolite, and Xs, XG1, XG2/M 
are observed fractions of the cells in each phase of the cycle at the 
Figure 6. Model showing the coordinated changes in lipid metabolism that support membrane synthesis from G2/M to G1 phase of the cell cycle. De 
novo FA synthesis increases from G2/M to G1 to support de novo phosphatidylcholine synthesis. During this time, the reacylation rate of LysopC sur-
passes pC deacylation, thus contributing to membrane accumulation (thick arrows). A reduction in AMpK-mediated inhibition of de novo FA synthe-
sis (dashed line) may coordinately regulate membrane synthesis and mitosis progression. An impaired membrane synthesis arrests the cells at G2/M, 
probably before ana/telophase, suggesting the presence of a “lipogenic checkpoint.” For simplicity the lipid metabolism from G1 to S and from S to 
G2/M are not depicted (gray). FA, fatty acid; LysopC, lysophosphatidylcholine; p-Chol, phosphocholine; CDp-Chol, CDp-choline; DAG, diacylglycerol; pC, 
phosphatidylcholine.
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time of harvesting (FACS analysis). Time of cell harvesting was 
also included in the model (τ), as it provided a more accurate fit 
to the data. Estimated coefficients βS, βG1, and βG2/M represent 
deconvoluted average values for metabolite levels at S, G
1
, and 
G
2
/M phase, respectively. Metabolites were considered to be 
changing in a cell cycle-dependent manner if the coefficient 
of variation of the estimated average levels was above the 75th 
percentile, and if the maximum fold change between any pair of 
the stages of the cell cycle was above the median. Next, inferred 
average levels of these metabolites were standardized across the 
cell cycle stages and clustered using PAM (partitioning around 
medoids) algorithm. Six clusters provided the best clustering, as 
assessed by silhouette plots.
Metabolic labeling and lipid analysis
Cells were synchronized as described above by 
2TB, released from the blockage in fresh media, and 
harvested after 4 h and every 2 h thereafter for up to 14 h. 
Two hours prior to harvesting, cells were labeled with 
1–2 μCi/dish of either [1-14C] acetic acid, [U-14C] glutamine, 
[1-14C] palmitic acid with 0.5% w/v bovine serum albumin, 
or [Methyl-14C] choline (American Radiolabeled Chemicals) 
in growing media. Alternatively, the cells were synchronized 
by thymidine-nocodazole, released in fresh media (or fresh 
nocodazole-supplemented media, time 0), and labeled for 
30 min with 3 μCi/dish [1-14C] Acetic acid at the indicated 
time point. The lipids were extracted as described by Bligh 
and Dyer56 and analyzed as described in reference 57. A brief 
description is provided in “Supplemental Methods”. For total 
fatty acid quantification, the cellular lipids were transesterified 
with 10% boron trif luoride in methanol for 1 h at 100 °C 
under a nitrogen atmosphere. The derivative methyl esters were 
separated by gas–liquid chromatography at the Laboratory 
for Lipid Medicine and Technology (LLMT), Massachusetts 
General Hospital,Harvard Medical School, and quantified 
using 23:0 as internal standard.
FASN activity
Subconfluent cells were treated with C75 20 μg/ml (or 
DMSO vehicle) for 24 h. Cells were lysed in hypotonic buffer 
(1 mM DTT, 1 mM EDTA, 20 mM TRIS-HCl pH 7.5) and 
incubated at room temperature for 15 min. Twenty micrograms 
of proteins were preincubated at 37 °C for 2 min with NADPH 
solution (100 mM potassium phosphate pH 7, 100 mM KCl, 0.5 
mM NADPH). The reaction was started by the addition of the 
substrate mixture (25 nmol Acetyl-CoA, 25 nmol Malonyl-CoA, 
0.05 uCi [2–14C] Malonyl-CoA, 164 uM final concentration of 
Acetyl- and Malonyl-CoA) and allowed to proceed for 10 min at 
37 °C. The reaction was stopped with the addition of ice-cold 1 N 
HCl:MOH (6:4 v/v). Fatty acids were extracted with petroleum 
benzin, and the radioactivity was determined by scintillation 
counting.
Dependence on FA
Subconfluent cells were treated with C75 20 μg/ml (or 
DMSO vehicle) for 24 h. Two hours prior to harvesting, the cells 
were incubated with BrdU and analyzed by FACS as described 
above. Alternatively, cells and conditioned media were harvested 
for immunoblotting analysis or cell number and viability 
determination using a Vi-Cell counter (Beckman). For the 
analysis of the exogenous FA dependence, cells were grown in 
10% regular or charcoal stripped FBS (CS-FBS) supplemented 
media. Cell number, viability, and cell cycle distribution were 
estimated as described above.
Incubation with AMPK activator
Subconfluent cells were treated with 25 μM AMPK activator 
MT 63-78 (Mercury Pharmaceuticals, Inc.) or DMSO vehicle 
with or without 100 μM palmitic acid (complexed with BSA in 
a 2:1 ratio) for 24 h. Cell cycle profile was assessed by FACS 
analysis with propidium iodide staining.
Immunoblotting
Cells were lysed in 1% NP-40 buffer with phosphatases and 
protease inhibitors. The lysates were cleared by centrifugation 
and 20 μg of protein, resolved on 4–12% Tris-glycine SDS-
polyacrylamide gels, were transferred to Hybond nitrocellulose 
membrane. The following antibodies were used: anti-cyclin B1, 
anti-D1, anti-phospho-Cdc2 (Tyr15), anti-phospho-ACC (Ser79), 
anti-ACC, anti-AMPKα, anti-phospho AMPKα (Thr172) (Cell 
signaling), anti-FASN (BD Transduction laboratories), anti-
Cyclin A (Santa Cruz Technology), anti-β-actin (Sigma).
Protein quantification
Total cellular protein content was quantified by the Bradford 
protein assay from Bio-Rad using bovine serum albumin as 
standard.
Statistical analysis
Statistically significant differences were assessed by one-way 
ANOVA and Tukey post-hoc test or Chi-square and Fisher Exact 
Test.
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